Cancer workforce crisis: 100 million staff shortfall projected by 2050, report warns
The Story
A new report presented at the American Society of Clinical Oncology’s annual meeting in Chicago warns that the world faces a projected shortfall of 100 million cancer care workers by 2050. The research, published in the Lancet, comes alongside a predicted 21% increase in cancer incidence, rising from 165 per 100,000 people in 2025 to 200 in 2050. Currently about 20 million people are diagnosed with cancer each year, but by 2050 that figure could reach 35.3 million – roughly 100,000 diagnoses per day. The largest staffing gaps are expected in nursing (about 65 million) and diagnostic staff (about 16 million). Co-author Mark Lawler, a professor at Queen’s University Belfast, called the findings a “wake-up call,” noting that as many as 18.5 million cancer deaths per year are projected by 2050. The report says that one in three cancer cases are currently undiagnosed worldwide, with up to 60% undiagnosed in some parts of Africa. The authors call for national cancer control plans, investment in technology, and public-private partnerships to address the crisis, estimating that action now could avert 170 million cancer deaths by 2050 and deliver about $120tn in net economic benefits.
Key Facts
- A report at the American Society of Clinical Oncology’s annual meeting in Chicago projects a shortfall of 100 million cancer care workers by 2050.
- The largest gaps are in nursing (65 million) and diagnostic staff (16 million).
- Cancer incidence is predicted to rise 21%, from 165 per 100,000 in 2025 to 200 in 2050.
- Annual cancer diagnoses are projected to increase from 20 million to 35.3 million by 2050 (nearly 100,000 per day).
- As many as 18.5 million cancer deaths per year are projected by 2050.
- Currently, one in three cancer cases are undiagnosed globally, with up to 60% undiagnosed in parts of Africa.
- In high-income countries, cancer survival is predicted to exceed 60% by 2050, but the workforce crisis will still affect them.
- Investing in the cancer workforce could avert 170 million cancer deaths between 2030 and 2050 and deliver about $120tn in net economic benefits.
Conflicting Reports
No conflicting reports identified in the source article.
Still Unclear
No open questions identified in the source article.
Misconceptions
No widespread misconceptions addressed in the source article.
Key Figures
- Mark Lawler, professor of digital health at Queen’s University Belfast, co-author of the report
- Dr. Hedvig Hricak, chair emeritus at Memorial Sloan Kettering Cancer Center, co-lead of the report
- Dr. Peter Kingham, director of Memorial Sloan Kettering’s global cancer research and training programme, co-author
Sources: The Guardian
